Search results
The FDA Could, Finally, Approve Novavax's Covid Vaccine — Is Novavax Stock A Buy?
Investor's Business Daily· 6 days agoBut the competitor vaccines have full FDA approval. Meanwhile, Novavax's shot has been available in...
Charles River (CRL) Partners to Reduce Animal Research Usage
Zacks via Yahoo Finance· 2 days agoCharles River Laboratories International, Inc. CRL recently announced the launch of its Virtual...
FDLI’s Top Cases 2024 Featuring Partner Andrew Wasson | JD Supra
JD Supra· 6 days agoPartner Andrew Wasson contributed a chapter to the Food & Drug Law Institute’s annual publication identifying the top food and drug cases of the year. Amgen v. Sanofi is undeniably ...
Digital Medicine Society partners with pharma giants for new digital endpoints project
FierceBiotech· 22 hours agoAbbvie, Merck, Roche, Genentech, Regeneron, Sanofi and other big names in biopharma have signed on...
Why Big-Name Biotech Regeneron Pharma Just Joined The 1,000-Club
Investor's Business Daily· 21 hours agoHis comments are based on a survey of 31 pulmonologists who treat patients with the damaging and...
Sarepta’s stock gains after Pfizer’s Duchenne trial failure - Boston Business Journal
The Business Journals· 3 hours agoSarepta Therapeutics, a Cambridge drugmaker known for its Duchenne muscular dystrophy treatments,...
Moderna’s combo COVID and flu vaccine works better than stand-alone shots on the market, study finds
Market Watch· 3 days agoexperimental combination COVID and flu vaccine triggered better immune responses than stand-alone...
GSK's RSV Vaccine Arexvy Gets FDA Nod for Adults 50-59 Years
Zacks via Yahoo Finance· 3 days agoModerna is also evaluating mRNA-1345 in early-stage studies for high-risk adults, as well as...
Moderna announces positive Phase III data for Covid-19/Influenza mRNA vaccine
Clinical Trials Arena via Yahoo Finance· 1 day agoModerna reported that a single dose of mRNA-1083 met immunogenicity non-inferiority criteria versus...
A Life Expansion Revolution Is Coming: 3 Stocks That Could Lead the Charge | The Motley Fool
The Motley Fool· 1 day agoThe human lifespan has increased dramatically since the start of the 17th century, from an average...